DK0474580T3 - Anvendelse af 1-(3-dimethylamino)propyl)-1-phenylphthalener til behandling af cerebrovaskulære sygdomme - Google Patents

Anvendelse af 1-(3-dimethylamino)propyl)-1-phenylphthalener til behandling af cerebrovaskulære sygdomme

Info

Publication number: DK0474580T3
Authority: DK; Denmark
Prior art keywords: dimethylamino; propyl; treatment; phenylphthalenes; cerebrovascular diseases
Prior art date: 1990-09-06

Application number

DK91610063.9T

Other languages

English (en)

Inventor

Yoshiaki Tanaka

Naomi Kobayashi

Tadashi Kurimoto

Yugo Ikeda

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-09-06

Filing date

1991-08-16

Publication date

1995-04-03

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26066379&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0474580(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1991-08-16 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

1995-04-03 Application granted granted Critical

1995-04-03 Publication of DK0474580T3 publication Critical patent/DK0474580T3/da

Links

208000026106 cerebrovascular disease Diseases 0.000 title abstract 2
206010012289 Dementia Diseases 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK91610063.9T 1990-09-06 1991-08-16 Anvendelse af 1-(3-dimethylamino)propyl)-1-phenylphthalener til behandling af cerebrovaskulære sygdomme DK0474580T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK213290A DK213290D0 (da)	1990-09-06	1990-09-06	Treatment of cerebrovascular disorders
SG165594A SG165594G (en)	1990-09-06	1994-11-16	1-[3-(dimethylamino)propyl]-1-phenylphthalenes for the treatment of cerebrovascular disorders

Publications (1)

Publication Number	Publication Date
DK0474580T3 true DK0474580T3 (da)	1995-04-03

Family

ID=26066379

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK213290A DK213290D0 (da)	1990-09-06	1990-09-06	Treatment of cerebrovascular disorders
DK91610063.9T DK0474580T3 (da)	1990-09-06	1991-08-16	Anvendelse af 1-(3-dimethylamino)propyl)-1-phenylphthalener til behandling af cerebrovaskulære sygdomme

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK213290A DK213290D0 (da)	1990-09-06	1990-09-06	Treatment of cerebrovascular disorders

Country Status (14)

Country	Link
EP (1)	EP0474580B1 (da)
JP (1)	JPH085787B2 (da)
KR (1)	KR970002246B1 (da)
AT (1)	ATE112166T1 (da)
AU (1)	AU644204B2 (da)
CA (1)	CA2049368C (da)
DE (1)	DE69104314T2 (da)
DK (2)	DK213290D0 (da)
HK (1)	HK21595A (da)
IE (1)	IE72160B1 (da)
IL (1)	IL98968A (da)
NZ (1)	NZ239437A (da)
SG (1)	SG165594G (da)
ZA (1)	ZA916187B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TR200000066T2 (tr) *	1997-07-08	2000-11-21	H. Lundbeck A/S	Sitalopram hazırlanması için yöntem.
JP4674339B2 (ja) *	1998-08-07	2011-04-20	三菱化学株式会社	脳損傷の予防・治療剤
PL199423B1 (pl) *	1998-10-20	2008-09-30	Lundbeck & Co As H	Sposób wytwarzania citalopramu
CN1149208C (zh)	1998-12-23	2004-05-12	H.隆德贝克有限公司	制备5-氰基2-苯并[c]呋喃酮的方法
NZ514671A (en)	1999-04-14	2003-10-31	H	Method for the preparation of citalopram
ITMI991581A1 (it) *	1999-06-25	2001-01-15	Lundbeck & Co As H	Metodo per la preparazione di citalopram
AR021155A1 (es) *	1999-07-08	2002-06-12	Lundbeck & Co As H	Tratamiento de desordenes neuroticos
GB2357762B (en)	2000-03-13	2002-01-30	Lundbeck & Co As H	Crystalline base of citalopram
BG64901B1 (bg) *	2000-05-29	2006-08-31	H. Lundbeck A/S	Метод за получаване на циталопрам
IL144817A0 (en)	2000-08-18	2002-06-30	Lundbeck & Co As H	Method for the preparation of citalopram
JP3798982B2 (ja) *	2000-12-22	2006-07-19	ハー・ルンドベック・アクチエゼルスカベット	純粋なシタロプラムの製造方法
BG65515B1 (bg) *	2002-07-26	2008-10-31	H. Lundbeck A/S	Метод за получаване на 5-цианофталид
WO2005060968A1 (en)	2003-12-11	2005-07-07	Sepracor Inc.	Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
TW200812993A (en) *	2006-05-02	2008-03-16	Lundbeck & Co As H	New uses of escitalopram
EP2008653A1 (de) *	2007-06-28	2008-12-31	Charité-Universitätsmedizin Berlin	Serotonerge Verbindungen zur Behandlung neuronaler Krankheiten
DE102007051090A1 (de)	2007-06-28	2009-01-08	Charité - Universitätsmedizin Berlin	SSRI zur Behandlung neuronaler Krankheiten
CN104005415B (zh) *	2014-02-18	2015-12-02	中铁十六局集团北京轨道交通工程建设有限公司	微风化花岗岩中地下连续墙的高效成槽施工方法
CN106871753B (zh) *	2017-01-04	2018-10-16	中铁隧道集团有限公司	一种用于提高水平岩层隧道成型的装药方法

1990
- 1990-09-06 DK DK213290A patent/DK213290D0/da not_active Application Discontinuation
1991
- 1991-07-25 IL IL9896891A patent/IL98968A/en not_active IP Right Cessation
- 1991-07-30 IE IE268291A patent/IE72160B1/en not_active IP Right Cessation
- 1991-08-06 ZA ZA916187A patent/ZA916187B/xx unknown
- 1991-08-16 DE DE69104314T patent/DE69104314T2/de not_active Expired - Lifetime
- 1991-08-16 DK DK91610063.9T patent/DK0474580T3/da active
- 1991-08-16 CA CA002049368A patent/CA2049368C/en not_active Expired - Lifetime
- 1991-08-16 NZ NZ239437A patent/NZ239437A/en not_active IP Right Cessation
- 1991-08-16 AT AT91610063T patent/ATE112166T1/de not_active IP Right Cessation
- 1991-08-16 EP EP91610063A patent/EP0474580B1/en not_active Expired - Lifetime
- 1991-08-19 KR KR1019910014255A patent/KR970002246B1/ko not_active Expired - Fee Related
- 1991-08-20 AU AU82594/91A patent/AU644204B2/en not_active Ceased
- 1991-09-04 JP JP3224192A patent/JPH085787B2/ja not_active Expired - Fee Related
1994
- 1994-11-16 SG SG165594A patent/SG165594G/en unknown
1995
- 1995-02-16 HK HK21595A patent/HK21595A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
SG165594G (en)	1995-05-12
ZA916187B (en)	1992-04-29
ATE112166T1 (de)	1994-10-15
JPH085787B2 (ja)	1996-01-24
EP0474580B1 (en)	1994-09-28
DE69104314T2 (de)	1995-02-16
DE69104314D1 (de)	1994-11-03
NZ239437A (en)	1997-02-24
AU644204B2 (en)	1993-12-02
KR970002246B1 (ko)	1997-02-26
IL98968A0 (en)	1992-07-15
IE72160B1 (en)	1997-03-26
DK213290D0 (da)	1990-09-06
CA2049368A1 (en)	1992-03-07
HK21595A (en)	1995-02-24
IE912682A1 (en)	1992-03-11
IL98968A (en)	1996-06-18
EP0474580A3 (en)	1992-06-03
KR920005983A (ko)	1992-04-27
CA2049368C (en)	2001-10-23
AU8259491A (en)	1992-03-12
EP0474580A2 (en)	1992-03-11
JPH04244024A (ja)	1992-09-01

Publication	Publication Date	Title
DK213290D0 (da)	1990-09-06	Treatment of cerebrovascular disorders
DK0646115T3 (da)	2003-04-22	Heterocykliske/cykliske aminderivater
NO922147L (no)	1992-12-01	Heterocykliske derivater
NO941052L (no)	1994-09-26	Benzimidazolforbindelser, deres anvendelse og fremstilling
SE0104332D0 (sv)	2001-12-19	Therapeutic agents
DK0530505T3 (da)	1996-02-12	Hydantoinderivater
DK441187D0 (da)	1987-08-24	Alfa-alkyl-4-amino-3-quinolinmethanoler og 1-(4-aralkylamino-3-quinolinyl)alkanoner, deres fremstilling og anvendelse
ATE180780T1 (de)	1999-06-15	2-(piperidin-4-yl, pyridin-4-yl und tetrahydropyridin-4-yl)-benzofuran-7-carbamat derivate, ihre herstellung und verwendung als acetylcholinesterase inhibitoren
NO920035D0 (no)	1992-01-02	Trifluormetylketon-derivater, og deres fremstilling og anvendelse
ATE106404T1 (de)	1994-06-15	Angiotensin-ii-antagonisten.
DK132188D0 (da)	1988-03-11	Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
DK26289A (da)	1989-07-22	Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
FI935800A0 (fi)	1993-12-22	Antidepressiva och mot Parkisons sjukdom verksamma foereningar
DE69018726D1 (de)	1995-05-24	Cumarinderivate, ihre Herstellung und ihre Verwendung zur Behandlung von zerebrovaskulären Störungen.
ES8602723A1 (es)	1985-12-01	Un procedimiento para la preparacion de nuevas n-bencil-propilaminas sustituidas.
ATE283269T1 (de)	2004-12-15	5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems
DE3650311D1 (de)	1995-06-01	Verwendung von Quinazolinen zur Herstellung eines Arzneimittels zur Behandlung und Vorbeugung von Arrhythmie.
DE69327077D1 (de)	1999-12-30	Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen